BIOMAT Database Logo BIOMAT Database Logo

[Action of T-activin on human natural killer activity in vitro]. 1986

S B Cheknev, and M Z Saidov, and L V Koval'chuk, and A S Pavliuk, and V Ia Arion

The activity of natural killers (NK) from human peripheral blood was determined by 3H-uridine test using target cells K-562. T-activin effect on the activity of human NK in vitro depended on two parameters: the preparation dose and effector/target cells ratio. The inhibitory effect of T-activin was observed with high doses and increased E/T ratio, while the activating effect was noted with low doses and reduced E/T ratio. This can be attributed to the heterogeneity of NK population, different functional role of high and low doses of thymic factors and the development of NK as T-cell precursors.

UI MeSH Term Description Entries
D007694 Killer Cells, Natural Bone marrow-derived lymphocytes that possess cytotoxic properties, classically directed against transformed and virus-infected cells. Unlike T CELLS; and B CELLS; NK CELLS are not antigen specific. The cytotoxicity of natural killer cells is determined by the collective signaling of an array of inhibitory and stimulatory CELL SURFACE RECEPTORS. A subset of T-LYMPHOCYTES referred to as NATURAL KILLER T CELLS shares some of the properties of this cell type. NK Cells,Natural Killer Cells,Cell, NK,Cell, Natural Killer,Cells, NK,Cells, Natural Killer,Killer Cell, Natural,NK Cell,Natural Killer Cell
D007951 Leukemia, Myeloid Form of leukemia characterized by an uncontrolled proliferation of the myeloid lineage and their precursors (MYELOID PROGENITOR CELLS) in the bone marrow and other sites. Granulocytic Leukemia,Leukemia, Granulocytic,Leukemia, Myelocytic,Leukemia, Myelogenous,Myelocytic Leukemia,Myelogenous Leukemia,Myeloid Leukemia,Leukemia, Monocytic, Chronic,Monocytic Leukemia, Chronic,Chronic Monocytic Leukemia,Chronic Monocytic Leukemias,Granulocytic Leukemias,Leukemia, Chronic Monocytic,Leukemias, Chronic Monocytic,Leukemias, Granulocytic,Leukemias, Myelocytic,Leukemias, Myelogenous,Leukemias, Myeloid,Monocytic Leukemias, Chronic,Myelocytic Leukemias,Myelogenous Leukemias,Myeloid Leukemias
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D010455 Peptides Members of the class of compounds composed of AMINO ACIDS joined together by peptide bonds between adjacent amino acids into linear, branched or cyclical structures. OLIGOPEPTIDES are composed of approximately 2-12 amino acids. Polypeptides are composed of approximately 13 or more amino acids. PROTEINS are considered to be larger versions of peptides that can form into complex structures such as ENZYMES and RECEPTORS. Peptide,Polypeptide,Polypeptides
D002478 Cells, Cultured Cells propagated in vitro in special media conducive to their growth. Cultured cells are used to study developmental, morphologic, metabolic, physiologic, and genetic processes, among others. Cultured Cells,Cell, Cultured,Cultured Cell
D004306 Dose-Response Relationship, Immunologic A specific immune response elicited by a specific dose of an immunologically active substance or cell in an organism, tissue, or cell. Immunologic Dose-Response Relationship,Relationship, Immunologic Dose-Response,Dose Response Relationship, Immunologic,Dose-Response Relationships, Immunologic,Immunologic Dose Response Relationship,Immunologic Dose-Response Relationships,Relationship, Immunologic Dose Response,Relationships, Immunologic Dose-Response
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000276 Adjuvants, Immunologic Substances that augment, stimulate, activate, potentiate, or modulate the immune response at either the cellular or humoral level. The classical agents (Freund's adjuvant, BCG, Corynebacterium parvum, et al.) contain bacterial antigens. Some are endogenous (e.g., histamine, interferon, transfer factor, tuftsin, interleukin-1). Their mode of action is either non-specific, resulting in increased immune responsiveness to a wide variety of antigens, or antigen-specific, i.e., affecting a restricted type of immune response to a narrow group of antigens. The therapeutic efficacy of many biological response modifiers is related to their antigen-specific immunoadjuvanticity. Immunoactivators,Immunoadjuvant,Immunoadjuvants,Immunologic Adjuvant,Immunopotentiator,Immunopotentiators,Immunostimulant,Immunostimulants,Adjuvant, Immunologic,Adjuvants, Immunological,Immunologic Adjuvants,Immunological Adjuvant,Adjuvant, Immunological,Immunological Adjuvants
D000293 Adolescent A person 13 to 18 years of age. Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults

Related Publications

S B Cheknev, and M Z Saidov, and L V Koval'chuk, and A S Pavliuk, and V Ia Arion
In vitro expanded human invariant natural killer T-cells promote functional activity of natural killer cells.
October 2008, Clinical immunology (Orlando, Fla.),
S B Cheknev, and M Z Saidov, and L V Koval'chuk, and A S Pavliuk, and V Ia Arion
Human T lymphocyte clones with killer or natural killer activity.
June 1986, Journal of immunological methods,
S B Cheknev, and M Z Saidov, and L V Koval'chuk, and A S Pavliuk, and V Ia Arion
Effect of D-glucosamine on human natural killer activity in vitro.
August 1984, Journal of biological response modifiers,
S B Cheknev, and M Z Saidov, and L V Koval'chuk, and A S Pavliuk, and V Ia Arion
Inhibitory effect of diazepam on human natural killer activity in vitro.
January 1994, Cytobios,
S B Cheknev, and M Z Saidov, and L V Koval'chuk, and A S Pavliuk, and V Ia Arion
The effect of a chimeric mouse-human CD7 antibody on human T, natural killer, and lymphokine-activated killer cell activity in vitro.
August 1991, Transplantation,
S B Cheknev, and M Z Saidov, and L V Koval'chuk, and A S Pavliuk, and V Ia Arion
Norepinephrine inhibits human natural killer cell activity in vitro.
May 1991, The International journal of neuroscience,
S B Cheknev, and M Z Saidov, and L V Koval'chuk, and A S Pavliuk, and V Ia Arion
Imaging natural killer T cells in action.
April 2013, Immunology and cell biology,
S B Cheknev, and M Z Saidov, and L V Koval'chuk, and A S Pavliuk, and V Ia Arion
Activin-A attenuates several human natural killer cell functions.
April 2009, Blood,
S B Cheknev, and M Z Saidov, and L V Koval'chuk, and A S Pavliuk, and V Ia Arion
[Effect T-activin on the activity of the natural killer cells after acute intoxication by toxic chemical substances].
January 2003, Eksperimental'naia i klinicheskaia farmakologiia,
S B Cheknev, and M Z Saidov, and L V Koval'chuk, and A S Pavliuk, and V Ia Arion
Hormonal modulation of human natural killer cell activity in vitro.
February 1985, Journal of reproductive immunology,
Copied contents to your clipboard!